Clinical trial NCT00717808 - References

Rheumatoid Arthritis — Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)

Citation(s)

•   Inglis JJ, Criado G, Andrews M, Feldmann M, Williams RO, Selley ML
  The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. Rheumatology (Oxford). 2007 Sep;46(9):1428-32. Epub 2007 Jul 21.
•   Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L
  Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science. 2005 Nov 4;310(5749):850-5. Erratum in: Science. 2006 Feb 17;311(5763):954.

A Phase 1, Blinded, Randomised, Crossover Pilot Study to Investigate the Safety, Tolerability and Pharmacokinetics of Tranilast in Patients With Rheumatoid Arthritis on Methotrexate

Details for clinical trial NCT00717808